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Both acquired and intrinsic mechanisms play a crucial role in Pseudomonas aeruginosa
antibiotic resistance. Many clinically relevant resistance mechanisms result from changes
in gene expression, namely multidrug efflux pump overproduction, AmpC β-lactamase
induction or derepression, and inactivation or repression of the carbapenem-specific
porin OprD. Changes in gene expression are usually assessed using reverse-transcription
quantitative real-time PCR (RT-qPCR) assays. Here, we evaluated label-free Selected
Reaction Monitoring (SRM)-based mass spectrometry to directly quantify proteins
involved in antibiotic resistance. We evaluated the label-free SRM using a defined set of
P. aeruginosa isolates with known resistance mechanisms and compared it with RT-qPCR.
Referring to efflux systems, we found a more robust relative quantification of antibiotic
resistance mechanisms by SRM than RT-qPCR. The SRM-based approach was applied
to a set of clinical P. aeruginosa isolates to detect antibiotic resistance proteins. This
multiplexed SRM-based approach is a rapid and reliable method for the simultaneous
detection and quantification of resistance mechanisms and we demonstrate its relevance
for antibiotic resistance prediction.
Keywords: SRM, Pseudomonas aeruginosa, multidrug efflux system, AmpC cephalosporinase, OprD porin,
carbapenem resistance, cephalosporin resistance, RT-qPCR
INTRODUCTION
Pseudomonas aeruginosa is an opportunistic bacterial pathogen
able to survive in diverse environments (Lyczak et al., 2000).
P. aeruginosa infections are predominantly hospital acquired and
represent a considerable therapeutic challenge (Giamarellou and
Kanellakopoulou, 2008). Selection of the appropriate antibiotic
drug to initiate therapy as quickly as possible is essential to
optimize the clinical outcome (Bisbe et al., 1988; Micek et al.,
2005). P. aeruginosa is intrinsically resistant to various antibi-
otics resulting from the combination of low outer membrane
permeability, induction or derepression of AmpC β-lactamase
and intrinsic or induced expression of efflux pumps (Poole,
2011). For instance, the constitutively expressed MexAB-OprM
Abbreviations: ESI, Electrospray Ionization; LC, Liquid Chromatography; MS,
Mass Spectrometry; RT-qPCR, Reverse Transcription quantitative PCR; SRM,
Selected Reaction Monitoring
and the inducible MexXY-OprM efflux systems extrude various
antibiotics from the major drug classes, thus contributing to
intrinsic resistance (Masuda et al., 2000). Furthermore, during
the course of antibiotic therapy, P. aeruginosa acquires resistance
through chromosomally-encoded mutations that lead to the con-
stitutive overexpression of RND-type efflux pumps and AmpC
cephalosporinase (Hocquet et al., 2007a; Cabot et al., 2011). 14
to 56% of failed therapy in patients under antipseudomonal ther-
apy have been observed due to AmpC derepression (Lister et al.,
2009). Moreover, the expression of the substrate-specific porin
OprD, promoting the entry of carbapenems, (Trias and Nikaido,
1990a,b), is frequently downregulated by both transcriptional
and translational mechanisms (Lister et al., 2009). That these
mechanisms are often present simultaneously in P. aeruginosa,
thereby conferring multiresistant phenotypes is of serious con-
cern (Livermore, 2002; Poole, 2011). A singlemethod detecting all
aforementioned mechanisms would be a useful aid for selecting
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the most appropriate antibiotic in order to counteract antibiotic
resistance emergence in this opportunistic pathogen.
Selected Reaction Monitoring (SRM) is a targeted Mass
Spectrometry-based (MS) technique that has favorable per-
formance characteristics compared with other MS techniques
(Domon and Aebersold, 2010). It makes use of triple quadrupole
mass spectrometers to selectively isolate precursor ions corre-
sponding to the mass of the targeted peptides and to selec-
tively monitor peptide-specific fragments. This particular mode
of operation provides a high level of selectivity and sensitivity
and a wide dynamic range of analysis even in complex samples
(Picotti et al., 2009). Suitable sets of precursor and fragment ion
masses for a given peptide, called SRM transitions, constitute
definitive MS assays that identify a peptide and, by inference, its
cognate protein in the proteome digests (Lange et al., 2008). An
additional advantage of SRM is the high degree of analyte multi-
plexing. Here we finalized a scheduled SRM method to quantify
antibiotic resistance mechanisms at the protein level. P. aerugi-
nosa-specific peptides have been simultaneously investigated to
normalize sample quantities by taking advantage of multiplex-
ing capacities. We also developed a generic sample preparation
and chromatographic separation method to be used prior to elec-
trospray ionization (ESI) triple quadrupole mass spectrometric
analysis. Our data show that a label-free SRM-based method sup-
ports the evaluation of antibiotic resistance mechanisms in both
laboratory and clinical strains.
MATERIALS AND METHODS
BACTERIAL STRAIN, ANTIBACTERIAL AGENTS, AND CHEMICALS
Strains of the literature-based set were previously characterized
(Table S1). Strains of the clinical-based set came from different
hospitals (Table S2). All strains were stored as glycerol stocks
at −80◦C. Subcultures were performed on Mueller-Hinton agar
medium (Becton Dickinson AG, Allschwil, Switzerland) at 37◦C
for 18 h in aerobic conditions. Strains were sub-cultured in 5mL
Lysogeny-Broth medium (Becton Dickinson AG) and grown dur-
ing 5 h at 37◦C with shaking. A 1mL aliquot was centrifuged at
3500 g during 10min and supernatant was discarded. Aliquots
taken from the same culture were used immediately or frozen
at −20◦C until use. One aliquot was used for RT-qPCR anal-
ysis and three aliquots were used for SRM analysis. All of the
samples were assayed in technical triplicates for both techniques
unless specified for SRM (Table S3). Antimicrobial disk diffusion
tests were performed according to the Clinical and Laboratory
Standards Institute (Table S4).
RT-qPCR EXPERIMENT
Isolation of total RNA
Lysis of bacterial cells was performed with 1mg/mL lysozyme in
Tris/EDTA buffer (10mM Tris-HCl, pH 8.0, containing 1mM
EDTA). Total RNA was isolated according to the instructions
of the supplier using a RNeasy kit (Qiagen, Hilden, Germany).
Residual DNA was eliminated by DNase treatment using 10U
of RNase-free DNase (Roche, Basel, Switzerland). DNase was
removed by repeating the column based purification and the
RNA was eluted with 30μL of RNase-free H2O. Purified RNA
was quantified using a spectrophotometer (ND-8000 NanoDrop
Technologies, Wilmington, DE) and stored at −80◦C. A reaction
mix containing 1μg of RNA was incubated in the presence of
250 ng random hexamers (Promega, Madison, United States) and
dNTPs (10mM final concentration) in a total volume of 13μL
at 65◦C for 5min. After chilling the mix on ice, 4μL of 5X
first strand buffer, 2μL of 100mM dithiotreitol (Sigma-Aldrich-
Fluka, Lyon, France) and 1μL of Superscript III™ reverse tran-
scriptase (Invitrogen, Carlsbad, CA) were added. Reactions were
incubated for 5min at 25◦C and then at 50◦C for 50min. Reverse
transcriptase was inactivated by incubation at 70◦C for 15min.
1μL of RNase H (Invitrogen) was added and the mix incubated
at 37◦C for 20min to degrade RNA. The cDNAs obtained were
purified using QIAquick PCR purification kit (Qiagen, Hilden,
Germany) following suppliers instructions and stored at −20◦C
until use.
RT-qPCR ANALYSIS
The primers for the PCR amplification of cDNA were retrieved
from literature sources or designed using the primer3 program
(Untergasser et al., 2012) (Table S5). An Mx3005P qPCR system
(Agilent, Santa Clara, United States) was used for the quantifi-
cation of cDNA. Triplicate PCR reactions were performed using
the Brilliant II SYBR Green Q-PCR Master mix (Agilent). Five
microliters of a 1 ng/μL cDNA concentration were used in a total
volume of 15μL. After a 10-min initial denaturation step, 40
cycles of 30 s at 95◦C and 60 s at 60◦C were performed. A melt
curve was run at the end of the 40 cycles to test for the pres-
ence of a unique PCR reaction product. To check for residual
contaminating genomic DNA, control reactions without reverse
transcriptase were analyzed in the same way using the rpsL-F/R
primers. The amount of signal in the controls was usually close to
the non-template control.
To correct for differences in the amount of starting material,
the ribosomal rpsL gene was selected as a housekeeping reference
gene. Results were presented as ratios of gene expression between
the target gene (target) and the reference gene (rpsL), which were
obtained according to the following equation:
ratio = E target
CP(Control−Sample)
E referenceCP(Control−Sample)
(Pfaffl et al., 2002), where E is the real-time PCR efficiency for
a given gene and CP the crossing point (CP) difference () of
the amplification curve with the threshold. PCR efficiencies were
corrected according to LinRegPCR program (Ruijter et al., 2009)
and the median of individual values was calculated for each gene.
SRM EXPERIMENT
Bacterial lysis and digestion
Frozen aliquots of bacterial pellets were thawed and introduced
into 1.5mL Eppendorf tubes, containing a mixture of glass beads
and 150μL of 50mM NH4HCO3, 5mM dithiotreitol (Sigma-
Aldrich-Fluka), pH = 8.0. The tubes were placed on an ultra-
sound probe (Hielscher Ultrasonics GmBH, Teltow, Germany)
and the samples were disrupted during 5min. They were further
alkylated with 12.5mM iodoacetamide (Sigma-Aldrich-Fluka)
during 5min in the dark. Trypsin (10μg) (Sigma-Aldrich-Fluka)
was added to the samples and the digestion was performed on a
heating block at 50◦C during 15min. The tryptic digestion was
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stopped by acidifying samples with 0.5μL formic acid (Sigma-
Aldrich-Fluka). The samples were desalted using Oasis HLB
3 cm3 (60mg) reversed phase cartridges (Waters, Milford, MA).
The cartridges were conditioned with 1mL of methanol (Merck
Millipore, Billerica, MA), then with 1mL of water (LC-MS grade,
Fisher Scientific, Strasbourg, France) containing 0.1% formic acid
prior to loading of the tryptic digest. Cartridges were washed
with 1mL of water containing 0.1% formic acid and eluted
with methanol/water (80:20, v/v) containing 0.1% formic acid.
The samples were dried by vacuum centrifugation, suspended in
200μL of water/acetonitrile (95/5, v/v) containing 0.5% of formic
acid and directly analyzed or stored at −20◦C until analysis.
LIQUID CHROMATOGRAPHY (LC) AND MASS SPECTROMETRY (MS)
ANALYSIS
Identification-based analysis was performed on an Ultimate 3000
HPLC instrument (Dionex Corporation, Sunnyvale, CA) cou-
pled to an hybrid triple quadripole/time of flight 5600 TripleTOF
(AB Sciex, Foster City, CA) equipped with an ESI Turbo V ion
source. LC separation was carried out on a XBridge BEH C18 col-
umn (150mm × 2.1mm, particle size 3.5μm, porosity 130Å)
fromWaters. Elution was performed at a flow rate of 300μL/min
with water (LC-MS grade, Fisher Scientific) containing 0.1% (v/v)
formic acid as solvent A and acetonitrile (LC-MS grade, Fisher
Scientific) containing 0.1% (v/v) formic acid as solvent B. An iso-
cratic step at 5% solvent B during 3min was followed by a 60-min
linear gradient from 5 to 45% solvent B. MS analysis was car-
ried out in positive ionization mode using an ion spray voltage
of 5500V. The nebulizer and the curtain gas flows were set at
50 psi using nitrogen. The Turbo V ion source was operated at
550◦C with the auxiliary gas flow (nitrogen) set at 50 psi. For
peptide identification, raw data were processed in ProteinPilot
v4.0 (AB Sciex) and searched using Paragon Algorithm (Shilov
et al., 2007) against SwissProt Pseudomonadales database (April
2013) using the following parameters. The search effort was Rapid
Identification, trypsin was specified for digestion, iodoacetamide
was specified for cysteine alkylation, and the instrument specified
was 5600TripleTOF. A protein score >1.3 from software supplier
(called Unused Prot Score) was used for scoring and selection
of proteins. Peptides were filtered using a peptide confidence
score >90.
Targeted analysis was performed in SRM mode on a Nexera
HPLC instrument (Shimadzu, Kyoto, Japan) hyphenated to an
hybrid triple quadripole/linear ion trap mass spectrometer 5500
QTRAP (AB Sciex) equipped with an ESI Turbo V ion source.
Instrument control, data acquisition and processing were per-
formed using Analyst 1.5.1 software. LC separation was carried
out on an XBridge BEH C18 column (100mm× 2.1mm, particle
size 3.5μm, porosity 130Å) fromWaters. Elution was performed
at a flow rate of 300μL/min with water (LC-MS grade, Fisher
Scientific) containing 0.1% (v/v) formic acid as solvent A and ace-
tonitrile (LC-MS grade, Fisher Scientific) containing 0.1% (v/v)
formic acid as solvent B. An isocratic step at 2% solvent B dur-
ing 3min was followed by a 22-min linear gradient from 2 to
35% solvent B. MS analysis was carried out in positive ioniza-
tion mode using an ion spray voltage of 5500V. The nebulizer
and the curtain gas flows were set at 50 psi using nitrogen. The
Turbo V ion source was operated at 550◦C with the auxiliary gas
flow (nitrogen) set at 50 psi.
SRM ASSAYS CONSTRUCTION
SRM assays were performed directly on digests from P. aeruginosa
cell pellets with a high content of proteins of interest. Antibiotic-
resistance proteins were digested in silico using Skyline software
(Maclean et al., 2010). All possible fully tryptic, doubly and triply
charged peptides that were between 7 and 20 amino acids in
length were selected. Carbamidomethyl cysteines were consid-
ered. For each peptide all singly and doubly charged product ions
from ion three to the last ion were selected. The threemost intense
transitions were selected based on library built with previous data
dependent analyses acquired on a 5600 TripleTOF (AB Sciex).
Collision energy and other settings were predicted according to
Skyline equations for 5500 QTRAP instrument and not opti-
mized further. Samples with a high content of proteins of interest
were injected in SRMmode with several methods. Based on these
results, retention times were adjusted and poorly responding pep-
tides were discarded. Previous data-dependent analyses allowed
us to select P. aeruginosa-specific peptide candidates for bacte-
rial quantification. Specificity to P. aeruginosa was evaluated by
BLAST analysis (Altschul et al., 1990). Non-specific peptides were
discarded as well as peptides containing methionine or missed-
cleavage sites. Digests of P. aeruginosa cell pellet were injected in
SRM mode. Simultaneously, retention times were adjusted and
poorly responding peptides were discarded while best responding
peptides were selected as candidates for bacterial quantification
and added in the final scheduled SRMmethod (Table S6).
DATA ANALYSIS
MultiQuantTM 2.1 software (AB Sciex), with the integration
algorithm Summation for peak integration, was used for SRM
data analysis. Peak integration parameters were set as follows with
a Gaussian smooth width of 1.0 point, a summation window of
10 s, a recentering window of 20 s around the expected retention
time and a 10% noise level for baseline.
NORMALIZATION METHOD
Vandesompele et al. has proposed an internal control gene-
stability measure calledM (Vandesompele et al., 2002). For every
control gene they determined the pairwise variation with all other
control genes as the standard deviation of the logarithmically
transformed expression ratios and definedM as the average pair-
wise variation of a particular gene with all other control genes.
We applied these equations (Vandesompele et al., 2002) for SRM
assays. M-values were calculated for each P. aeruginosa-specific
transition and averaged by peptide. A stepwise exclusion strat-
egy was chosen until average M-values were below 0.7. Peptides
and associated transitions that respected these rules were selected
for the internal control protein-stability measureM (Table S7). To
take into account the response factor, individual transition areas
values were divided by the average transition area. Averages were
based on samples with transition areas above 3000 arbitrary units
(a.u.). Contrary to Vandesompele et al. a median was preferred
to a geometric mean to reduce the effect of outliers. The normal-
ization factor (NF) used for each sample was the median of these
ratios.
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QUANTOTYPIC PEPTIDES SELECTION
Quantotypic peptides are stoichiometric to the level of each
protein (Worboys et al., 2014). Selection of quantotypic pep-
tides were based on Pearson correlation. Correlation analysis was
performed with Pearson’s product moment correlation on log-
normalized areas of transitions. A critical value of >0.8 was fixed
to be a relevant transition as surrogate of protein level. For a given
transition, when two correlation analyses from different peptides
did not respect this rule, the transition was excluded from the
median calculation (Table S8). Correlation were based on samples
with transition areas above 2000 a.u..
PROTEIN QUANTIFICATION
The underlying assumption for protein quantification in bottom-
up proteomics is that the level of the measured peptides is
stoichiometric to the level of the protein. To take into account
the response factor, individual transition area values were divided
by the average transition area. Averages were based on samples
with transition areas above 3000 a.u.. The protein abundance
estimation was the median of these ratios.
PROTEIN RATIO
For each sample, protein ratios were compared to a control
sample using the following equation:
protein ratio =
(
median target
median NF
)
sample .
(
median NF
median target
)
control
where target corresponds to the protein of interest and NF to the
normalization factor.
OprD PROTEIN CASE
The OprD porin presents substantial polymorphism (Pirnay
et al., 2002), seven representative protein sequences were retrieved
from Uniprot database (Uniprot release 2013_03). Based on
SRM results, four combinations of peptides (SRM profile) were
observed and led to five types of protein sequences (Table S9).
To take into account the response factor, individual transition
area values were divided by the average transition area. Averages
were based on samples with transition areas above 2000 a.u..
However, a different average was obtained for each SRM profile.
Common peptides among SRM profiles allowed the calculation
of a corrective factor (Table S9).
RESULTS
To assess the possibility of using SRM to detect antimicrobial
resistance mechanisms in P. aeruginosa, we measured, simulta-
neously, protein production of the four major efflux pumps, the
chromosomal AmpC β-lactamase and the porin OprD in dif-
ferent strains. The approach was compared to RT-qPCR which
has been used previously (Dumas et al., 2006). Initially, the
approach was assessed thanks to a literature-based set of strains
for which resistance mechanisms were well characterized (Table
S1). Subsequently, the approach was compared to a clinical-
based set of strains for which resistance mechanisms were to be
determined (Table S2).
EVALUATION OF EFFLUX SYSTEM EXPRESSION IN THE
LITERATURE-BASED SET
P. aeruginosa harbors 12 RND-type efflux pumps on its chromo-
some, however only the MexAB-OprM, MexCD-OprJ, MexEF-
OprN, and MexXY pumps have been shown to be of clinical
relevance (Poole et al., 1993, 1996; Köhler et al., 1997; Mine et al.,
1999). Among the strain test set, isolates known in the literature
to have a basal level expression of efflux system were used to assess
the distribution of basal level expression. Strains with expression
levels statistically above this distribution were considered as efflux
pump overexpressers. Using this classification scheme for both
strain sets, we found that, LC-ESI-SRM outperformed RT-qPCR
in the literature-based set (Table 1). Classification of efflux sys-
tem expression levels was 100% in agreement with literature data
using SRM compared to 93% using RT-qPCR.
Discrepancies were mainly observed for the MexAB-OprM
efflux system (Figure 1; Table S10). Five strains (1217, 1562, 2085,
2151, and 2172) expected to be overexpressed for this tripartite
system were not correctly classified using RT-qPCR. However,
strains producing basal level expression were correctly assigned
by RT-qPCR, except for strain 2112S. Based on results, a two-
fold change or less was sufficient to consider this efflux system
as overproduced. The correlation coefficient between MexA and
MexB subunits production was 0.98 for SRM and only 0.93 for
RT-qPCR analysis of mexA and mexB gene expression (Figures
S1–S2). Nevertheless, we had to pinpoint a correlation coeffi-
cient about 0.84 between MexA protein and mexA RNA analyses
(Figure S3).
In contrast to the constitutively expressed MexAB-OprM
efflux system, the MexCD-OprJ pump is expressed at clinically
relevant levels only when mutations arise in the cognate repressor
gene nfxB (Hosaka et al., 1995). Unfortunately, none of the strains
in the literature-based set was an nfxB mutant. Both techniques
classified correctly each strain (Figure 1; Table S11). Notably, pro-
tein production was undetectable in these strains. This observa-
tion was in agreement with the fact that the mexCD-oprJ operon
is not constitutively expressed (Hosaka et al., 1995).
The mexEF-oprN operon is positively regulated by the LysR-
type activator proteinMexT and is overexpressed in nfxCmutants
(Köhler et al., 1997, 1999). Both techniques classified correctly
each strain except 615R which was classified as overexpresser by
RT-qPCR (Figure 1; Table S12). Interestingly, a low level of pro-
tein production was detected in this strain and undetected inmost
of the other strains. Conversely, RT-qPCR seemed to be too sen-
sitive and did not reflect a real overexpression. A threshold may
be applied to compensate for RT-qPCR sensitivity. Nevertheless,
both techniques were precise based on correlation coefficients
(Figures S4, S5, R2 = 0.98).
MexXY-OprM is involved in the intrinsic and acquired resis-
tance of P. aeruginosa to aminoglycoside antibiotics (Aires et al.,
1999). The mexXY operon does not contain a gene coding for
an outer membrane protein but is able to recruit OprM of the
MexAB-OprM efflux pump to form a functional tripartite efflux
system (Mine et al., 1999). Because mutational events in the reg-
ulators may lead to the constitutive overproduction of MexXY
in clinical strains (Morita et al., 2012), the MexXY efflux system
was measured under non inducing conditions. Both RT-qPCR
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Table 1 | Classification of efflux systems status among P. aeruginosa strains in the literature-based set.
Efflux systems Expected result Strains classified according to
LC-ESI-SRM (protein) RT-qPCR (mRNA)
Basal level Over-produced Basal level Over-expressed
MexAB-OprMa Basal level (n = 17) 17 0 16 1
Over-expressed (n = 12) 0 12 5 7
MexCD-OprJb Basal level (n = 29) 29 0 29 0
Over-expressed (n = 0) 0 0 0 0
MexEF-OprNc Basal level (n = 22) 22 0 21 1
Over-expressed (n = 7) 0 7 0 7
MexXYd Basal level (n = 14) 14 0 13 1
Over-expressed (n = 15) 0 15 0 15
A two-sample two-sided t-test was performed on strains with basal level efflux system expression. For each subunit of efflux system, 95% confidence intervals
were deduced.
aOverexpression was significant when MexA/mexA and MexB/mexB measurements were above the confidence interval.
bOverexpression was significant when mexC and mexD measurements were above the confidence interval. Basal level strains did not have detectable MexC or
MexD protein production.
cOverexpression was significant when mexE and mexF measurements were above the confidence interval. Strains expressing efflux systems at a basal level did
not have detectable MexE or MexF protein production except for 4 strains allowing to estimate basal level production.
d Overexpression was significant when mexX and mexY measurements were above the confidence interval.
and SRM techniques were able to correctly classify each strain
(Figure 1; Table S13) except for strain 2112S with RT-qPCR.
Referring to MexXY basal-level producer strains, the highest
MexY protein quantity was observed in strain 2112S. These results
were in agreement with immunodetection of MexY reported by
Vogne et al. in this strain (Vogne et al., 2004). RT-qPCR detected
similar mexXY transcript quantities in these paired strains 2112S
and 2112R. Post-transcriptional events may occur in these paired
isolates preventing to know clinical relevance in strain 2112S
thanks to RT-qPCR. Both SRM and RT-qPCR yielded excellent
correlations between either MexX and MexY proteins or mexX
and mexY mRNAs (respectively, R2 = 0.99 and 0.94, Figures S6,
S7) whereas there was no correlation between OprM and either
MexX or MexY (respectively, R2 = 0.24 and 0.28, Figures S8, S9)
supporting independent expression ofmexXY and oprM.
EVALUATION OF EFFLUX SYSTEM EXPRESSION IN THE
CLINICAL-BASED SET
Overexpression of mexAB-oprM has been detected in nalB-,
nalC-, and nalD-type multidrug resistant mutants, selected both
in vivo and in vitro (Lister et al., 2009). In 6 out of 15 clinical
strains, overproduction was detected by LC-ESI-SRM (Table 2;
Table S10). Correlation between amounts of MexA and MexB
protein corroborated this result (R2 = 0.98 and slope = 0.976,
Figure S10). In contrast, RT-qPCR failed to classify 5 out of 6
strains as mexAB overexpressers (Table 2; Table S10). The only
strain (Pa-006) classified as mexAB over-expresser by RT-qPCR
had the highest-fold change ratios for mexA and mexB which
were statistically significant. Lack of precision for other strains
is reflected by the low correlation coefficient between mexA
and mexB mRNA expression (R2 = 0.725 and slope = 1.797,
Figure S11).
Given the crucial role of the complement in the host defense
against P. aeruginosa infections, nfxBmutants emerged rarely and
mainly in patients with compromised complement levels such
as isolates from cystic fibrosis patients with chronic respiratory
infections (Jalal et al., 2000; Mueller-Ortiz et al., 2004; Martinez-
Ramos et al., 2014). Indeed, mutation of nfxB has been reported
to be involved in the early adaptation to the chronic setting (Rau
et al., 2010). In 3 out of 15 strains, overproduction of MexCD-
OprJ was detected by SRM and RT-qPCR. Both techniques
seemed to classify correctly each strain (Table 2; Table S11).
Neither RT-qPCR nor SRM identified MexEF-OprN over-
producers among the 15 clinical isolates, supporting the idea
that they are rarely found in clinical settings (Hocquet et al.,
2007b). Protein expression levels of MexEF-OprN were unde-
tectable using SRM. Although mexE, mexF or oprN overexpres-
sion was detected in some of the isolates by RT-qPCR, none
of them fulfilled the criteria to be considered as a mexEF-oprN
overexpresser.
Both techniques were able to classify correctly MexXY over-
expression except for two strains (Pa-007, Pa-010). In these two
strains only mexY was overexpressed but not mexX. Based on
SRM measurements, the MexXY efflux system was overproduced
in 10 out of 15 clinical strains.
AmpC-MEDIATED RESISTANCE
The inducible cephalosporinase AmpC (Livermore, 1995) was
measured under non-inducing conditions. AmpC derepression
enabled to predict resistance to antipseudomonal penicillins or
cephalosporins thanks to a threshold level. AmpC expression
levels were compared to antibiogram phenotypes (Table S4).
SRM and RT-qPCR predicted antibiotic resistance most read-
ily when production or expression levels were 3 times and 15
times higher than those of PAO1, respectively. Only 3 discrep-
ancies out of 44 strains analyzed were observed between the
two techniques (Table S14). For two strains (1237 and Pa-001),
RT-qPCR detected ampC-derepression but not SRM, while strain
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FIGURE 1 | Protien and mRNA measurements of efflux
systems among P. aeruginosa strains in the literature-based
set. (A,C,E). Protein measurements of MexAB-OprM,
MexEF-OprN and MexXY(-OprM), respectively. (B,D,F). mRNA
measurements mexA, mexB, mexE, mexF and mexX, mexY
efflux genes, respectively.
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Table 2 | Comparison of LC-ESI-SRM vs. RT-qPCR results to classify
efflux systems status among P. aeruginosa clinical isolates.
Efflux systems Strains classified according to
LC-ESI-SRM (protein) RT-qPCR (mRNA)
Basal level Over-expressed
MexAB-OprM Basal level (9) 9 0
Over-produced (6) 5 1
MexCD-OprJ Basal level (12) 12 0
Over-produced (3) 0 3
MexEF-OprN Basal level (15) 15 0
Over-produced (0) 0 0
MexXY Basal level (5) 5 0
Over-produced (10) 2 8
The same cutoffs used in the literature-based set were applied to the clinical-
based set. Strains expressing efflux systems at a basal level did not have
detectable MexC or MexD protein production. Overproduction was considered
significant when MexC and MexD were detectable in the clinical-based set.
PT1155 was identified as AmpC derepressed by SRM but not
by RT-qPCR. The antibiogram suggested that AmpC was not
derepressed in strain 1237 and in strain Pa-001 an extended-
spectrum β-lactamase has been identified preventing assump-
tions on phenotype (Table S5). In the previously characterized
strain PT1155, AmpC was derepressed by SRM but showed an
increase close to the threshold by RT-qPCR. Overall, label-free
SRM-based AmpC detection predictions showed a better consis-
tency with the antibiogram data than RT-qPCR. The label-free
SRM approach showed agreement with disk diffusion assays of
88, 95, and 90% for piperacillin/tazobactam, ceftazidime and
cefepime, respectively (Table 3). The RT-qPCR approach showed
agreement with disk diffusion assays of 88, 93, and 90% for
piperacillin/tazobactam, ceftazidime and cefepime, respectively
(Table 4).
OprD-MEDIATED RESISTANCE
OprD loss enabled prediction of carbapenem resistance based
on the established threshold level of 20 times and 5 times lower
expression levels than those of PAO1 for SRM and RT-qPCR,
respectively. Levels were assigned according to meropenem and
imipenem susceptibilities. Notably 4 discrepancies out of 41 were
observed between the two techniques (Table S15). For these
strains (504, 1237, 2112S, 2112R), SRM detected OprD deficiency
whereas RT-qPCR did not, despite a consensus design of primers.
Antibiotic susceptibility testing confirmed SRM results as the
four strains were resistant to meropenem and imipenem (Table
S4). These results may suggest non-transcriptional events pre-
venting OprD insertion in these strains (misfolding, enzymatic
degradation, no outer membrane insertion by the Bam com-
plex. . . ). Overall, label-free SRM-based OprD detection was the
best predictor for carbapenem resistance. Agreements with stan-
dard procedures were 85 and 90% for imipenem andmeropenem,
respectively, using SRM-based OprD quantification (Table 3)
while agreements with standard procedures were 74 and 79% for
Table 3 | Protein-based prediction of antipseudomonal antibiotic
resistance and agreement with disk diffusion.
Protein-based Drugs Agreement with Minor Major Very
prediction disk diffusion error error major
(number of error
strains; %)
Highly reduced imipenem 35 5 0 1
OprD productiona 85.4% 12.2% 0.0% 2.4%
meropenem 37 3 1 0
90.2% 7.3% 2.4% 0.0%
Derepressed PIP/TAZOc 36 4 1 0
AmpCb 87.8% 9.8% 2.4% 0.0%
ceftazidime 39 1 1 0
95.1% 2.4% 2.4% 0.0%
cefepime 37 1 2 1
90.2% 2.4% 4.9% 2.4%
aHighly reduced OprD protein production, defined as 20 times less produced
than PAO1 level measured by LC-ESI-SRM, predicted carbapenem resistance,
otherwise susceptible.
bDerepressed AmpC protein, defined as 3 times more produced than PAO1 level
without induction measured by LC-ESI-SRM, predicted piperacillin/tazobactam,
ceftafidime and cefepime resistance, otherwise susceptible.
cPIP/TAZO corresponds to piperacillin/tazobactam combination. The error rate
determination is as follow: Minor error – reference result is R or S and device
result is I; reference result is I and device result is R or S. Major error – reference
result is S and device result is R. Very major error – reference result is R and
device result is S.
imipenem and meropenem, respectively, using RT-qPCR-based
oprD quantification (Table 4).
DISCUSSION
STRENGTHS ANDWEAKNESSES OF SRM vs. RT-qPCR
1/ Weak under- and over-expression
Weak under- and over-expression, as illustrated byMexAB-OprM
efflux system, were more precisely assessed using protein quan-
tification rather than mRNA quantification. Various reasons can
explain this observation. The first relates to the accuracy of the
antimicrobial resistance mechanism measure. For each antimi-
crobial resistance mechanism (protein or gene), multiple inde-
pendent assays per replicate called transitions were performed for
SRM whereas only one assay per replicate was performed for RT-
qPCR as is typically the case. In targeted proteomics, it is critical
that peptides are not only proteotypic but also accurately repre-
sent the level of the protein (quantotypic). As recently proposed
by Worboys et al. (2014), selection of quantotypic peptides was
performed according to a Pearson correlation between pairs of
transitions across samples. Both mRNA and peptides could be
unstable but in the case of SRM, the more stable peptides were
selected and averaged to reduce the variance. A second reason
relates to the accuracy of the normalization step. The normal-
ization of sample quantity is a very critical step. For RT-qPCR,
internal control genes called housekeeping genes assume that role.
Vandesompele et al. clearly showed that geometric averaging of
multiple and well-selected internal control genes improve the
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Table 4 | RNA-based prediction of antipseudomonal antibiotic
resistance and agreement with disk diffusion.
RNA-based Drugs Agreement with Minor Major Very
prediction disk diffusion error error major
(number of error
strains; %)
Highly reduced imipenem 28 5 0 5
oprD expressiona 73.7% 13.2% 0.0% 13.2%
meropenem 30 3 1 4
78.9% 7.9% 2.6% 10.5%
Derepressed PIP/TAZOc 36 4 1 0
ampCb 87.8% 9.8% 2.4% 0.0%
ceftazidime 38 1 1 1
92.7% 2.4% 2.4% 2.4%
cefepime 37 1 2 1
90.2% 2.4% 4.9% 2.4%
aHighly reduced oprD mRNA expression, defined as 5 times less expressed than
PAO1 level measured by RT-qPCR, predicted carbapenem resistance, otherwise
susceptible.
bDerepressed ampC mRNA, defined as 15 times more produced than PAO1
level without induction measured by RT-qPCR, predicted piperacillin/tazobactam,
ceftafidime and cefepime resistance, otherwise susceptible.
cPIP/TAZO corresponds to piperacillin/tazobactam combination. The error rate
determination is as follow: Minor error – reference result is R or S and device
result is I; reference result is I and device result is R or S. Major error – reference
result is S and device result is R. Very major error – reference result is R and
device result is S.
accuracy of normalization compared to single control normaliza-
tion (Vandesompele et al., 2002). It should be possible to measure
various housekeeping genes but at the cost of a higher workload
and price. For RT-qPCR, a single control gene procedure was
therefore performed while multiple peptides were assayed and
selected effortlessly for the internal control protein-stability mea-
sure. A third reason is the multiplexing capacity. Multiplexing of
RT-qPCR is possible but is limited by fluorescence labels to six
genes. Conversely, SRM present the advantage of having a higher
multiplexing capacity.
2/ Protein functionality and antibiotic resistance prediction
A restriction inherent to gene expression analysis is that pres-
ence of a transcript does not necessarily mean that it encodes
a functional protein. Additional regulatory events can affect
protein production. At least four cases of additional regula-
tion for OprD and one case for MexXY-OprM were suspected
with RT-qPCR. In contrast, protein detection has the ability to
delineate the functional units of a cell and is more likely to
predict the phenotypic differences such as antibiotic suscepti-
bility. Overproduction of efflux systems contributed to reduce
susceptibilities to cephalosporins and carbapenems but these were
not the main resistance mechanisms (Wang et al., 2010; Cabot
et al., 2011). Although antibiotic resistance implies various mech-
anisms, predictions were only based on one protein. Prediction of
anti-pseudomonal cephalosporin resistance was based on AmpC
detection, while prediction of carbapenem resistance was based
on OprD detection. Both proteins measured by SRM gave accu-
rate antimicrobial susceptibility prediction in accordance with
phenotypic methods.
3/ Sensitivity to genetic polymorphism
Design of primers for RT-qPCR experiments can be difficult
because of genetic sequence polymorphism which could be the
case for oprD gene expression (Pirnay et al., 2002). Low tran-
scripts could artificially appear due to primer non-hybridization
because of polymorphism. For SRM, knowledge of protein
sequence is mandatory but various specific peptides could be
detected. For example, three to four peptides per protein were
independently detected, giving SRM more autonomy to detect
OprD genetic polymorphism.
STRENGTHS ANDWEAKNESSES OF LABEL-FREE SRM vs. OTHERS
MASS SPECTROMETRY-BASED TECHNIQUES
Several mass spectrometry-based approaches have been used to
perform quantitative proteomics and have been reviewed recently,
for instance, to study carbapenem resistance in Acinetobacter bau-
mannii (Tiwari and Tiwari, 2014). Here, we deliberately chose a
bottom-up approach and more precisely a peptide-centric strat-
egy because separation, solubilization, ionization, and fragmenta-
tion of peptides was easier and more effective than for the parent
proteins. A targeted approach was rationally preferred to a shot-
gun approach. Reproducibility is lacking for shotgun approaches
(Tabb et al., 2010) and identification is limited to database
exhaustiveness (Duncan et al., 2010). SRM is the dedicated tar-
geted approach and was therefore selected. Two challenges for
effective relative quantification have been overcome: normaliza-
tion of sample quantity and estimation of protein abundance.
Classically, addition of stable isotopes through peptides, proteins
or bacteria is used to improve the precision. However, labeled
peptides or protein would be inadequate to normalize sample
quantities through the experiment since bacteria quantities and
bacterial lysis would not be exactly the same between samples.
Moreover, labeling of bacteria is really cumbersome and expen-
sive. Addition of stable isotopes was therefore discarded because
of convenience and price. Tagging of samples was also possible
but techniques were limited to 10 samples (McAlister et al., 2012)
and sample preparation also became cumbersome and expen-
sive. Consequently, a label-free approach was deliberately chosen.
Quantification was based on the principle claiming a direct rela-
tionship between signal measured and amount of analytes present
in a sample. For label-free quantification, all the issues that may
impair quantification accuracy and precision accumulate. It was
decided to keep sample preparation as short as possible, to use
a very stable HPLC system (microflow chromatography) and to
process all samples in the same experiment in order to prevent
reproducibility issues.
In conclusion, the SRM method shows results that are equiv-
alent or even better than those provided by RT-qPCR and the
method is generic, rapid, multiplexed and applicable beyond
genetic polymorphisms. It was able to detect antibiotic resistance
mechanisms including the AmpC cephalosporinase, the OprD
porin and the four major efflux pumps in both laboratory and
clinical strains. A generic sample preparation without detergent
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enables to quantify integral membrane proteins. SRM-based
predictions of antibiotic resistance proved to be accurate for
cephalosporin and carbapenem susceptibilities. As multidrug
resistance of P. aeruginosa involves several resistance mechanisms,
this multiplexed method should allow a more educated choice of
antimicrobial treatment.
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